We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ACLX market cap is 4.28B. The company's latest EPS is USD -1.3073 and P/E is -60.51.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 14.96M | 63.15M | 39.26M | 27.38M | 26.03M |
| Operating Income | -44.86M | 15M | -15.81M | -34.99M | -33.62M |
| Net Income | -39.34M | 19.84M | -7.2M | -27.2M | -25.87M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 110.32M |
| Operating Income | -65.02M | -191.26M | -89.88M |
| Net Income | -64.97M | -188.68M | -70.69M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 614.22M | 825.13M | 779.7M | 734.31M | 764.91M |
| Total Liabilities | 348.09M | 339.75M | 283.12M | 247.14M | 281.89M |
| Total Equity | 266.13M | 485.38M | 496.57M | 487.16M | 483.02M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 128.78M | 313.82M | 825.13M |
| Total Liabilities | 16.92M | 108.86M | 339.75M |
| Total Equity | -121.52M | 204.95M | 485.38M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | 149.33M | 207.57M | -31.91M | -68.16M | -37.44M |
| Investing | -175.53M | -154.51M | -206.81M | -214.69M | -178.93M |
| Financing | 90.57M | 279.16M | -2.99M | -13.41M | -18.07M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -54.24M | -99.3M | 207.57M |
| Investing | -79.98M | -117.67M | -154.51M |
| Financing | 118.45M | 252.63M | 279.16M |
| Market Cap | 4.28B |
| Price to Earnings Ratio | -60.51 |
| Price to Sales Ratio | 38.77 |
| Price to Cash Ratio | 10.84 |
| Price to Book Ratio | 8.81 |
| Dividend Yield | - |
| Shares Outstanding | 54.07M |
| Average Volume (1 week) | 580.38k |
| Average Volume (1 Month) | 602.55k |
| 52 Week Change | 36.11% |
| 52 Week High | 107.3699 |
| 52 Week Low | 47.88 |
| Spread (Intraday) | 51.41 (40.16%) |
| Company Name | Arcellx Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.arcellx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
